Volume 65, Issue 2, Pages (February 2004)

Slides:



Advertisements
Similar presentations
Volume 62, Pages S12-S22 (December 2002)
Advertisements

Inflammatory cytokines in acute renal failure
Volume 74, Issue 3, Pages (August 2008)
Volume 78, Issue 3, Pages (August 2010)
Volume 68, Issue 2, Pages (August 2005)
Volume 76, Issue 1, Pages (July 2009)
Volume 78, Issue 4, Pages (August 2010)
Volume 54, Issue 1, Pages (July 1998)
Volume 81, Issue 9, Pages (May 2012)
Volume 54, Issue 3, Pages (September 1998)
Volume 57, Issue 4, Pages (April 2000)
Volume 67, Issue 3, Pages (March 2005)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 81, Issue 9, Pages (May 2012)
Volume 61, Issue 5, Pages (May 2002)
Volume 58, Issue 6, Pages (December 2000)
Volume 74, Issue 3, Pages (August 2008)
Volume 62, Issue 1, Pages (July 2002)
Volume 79, Issue 3, Pages (February 2011)
Volume 60, Issue 3, Pages (September 2001)
Volume 75, Issue 9, Pages (May 2009)
Volume 54, Issue 3, Pages (September 1998)
Volume 63, Issue 4, Pages (April 2003)
Volume 65, Issue 6, Pages (June 2004)
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Volume 59, Issue 5, Pages (May 2001)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Volume 63, Issue 5, Pages (May 2003)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Volume 64, Pages S39-S45 (October 2003)
Volume 57, Issue 5, Pages (May 2000)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 63, Issue 2, Pages (February 2003)
Volume 60, Issue 6, Pages (December 2001)
Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,
Volume 69, Issue 2, Pages (January 2006)
Renal fibroblast-like cells in Goodpasture syndrome rats
Volume 57, Issue 3, Pages (March 2000)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Volume 61, Issue 1, Pages (January 2002)
Volume 64, Issue 3, Pages (September 2003)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 65, Issue 2, Pages (February 2004)
Expression of connective tissue growth factor in human renal fibrosis
Volume 68, Issue 6, Pages (December 2005)
Volume 77, Issue 4, Pages (February 2010)
Volume 85, Issue 2, Pages (January 2014)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 65, Issue 1, Pages (January 2004)
Volume 62, Pages S12-S22 (December 2002)
Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill 
Volume 54, Issue 4, Pages (October 1998)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 65, Issue 6, Pages (June 2004)
Contribution of tubular injury to loss of remnant kidney function
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 60, Issue 5, Pages (November 2001)
Volume 58, Issue 3, Pages (September 2000)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 58, Issue 4, Pages (October 2000)
Volume 56, Issue 6, Pages (December 1999)
Volume 55, Issue 2, Pages (February 1999)
Volume 21, Issue 2, Pages (February 2013)
Volume 59, Issue 2, Pages (February 2001)
Volume 65, Issue 6, Pages (June 2004)
Volume 65, Issue 1, Pages (January 2004)
Volume 70, Issue 1, Pages (July 2006)
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 65, Issue 2, Pages 409-419 (February 2004) Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury  Lance D. Dworkin, Rujun Gong, Evelyn Tolbert, Jason Centracchio, Nahiro Yano, Abdul R. Zanabli, Alfredo Esparza, Abdalla Rifai  Kidney International  Volume 65, Issue 2, Pages 409-419 (February 2004) DOI: 10.1111/j.1523-1755.2004.00417.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Representative light micrographs of kidney cortex from a remnant kidney from a control rat that received vehicle (A) as compared to a rat that received intravenous hepatocyte growth factor (HGF) (B) for two weeks. The kidney in (A) shows the typical findings in remnant kidneys at 4weeks after ablation including glomerular sclerosis, interstitial inflammation, tubular atrophy, and cast formation. Although some interstitial inflammation is observed, glomerular and tubular architecture are better preserved in the HGF-treated rat (B). (PAS, × 40). Kidney International 2004 65, 409-419DOI: (10.1111/j.1523-1755.2004.00417.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Glomerular and tubulointerstitial injury scores in control and hepatocyte growth factor (HGF)-treated remnant rats. There was a significant reduction in interstitial injury in the HGF group. CON, control rat; HGF, HGF-infused rat; –G, glomerular injury score; –I, interstitial injury score. Kidney International 2004 65, 409-419DOI: (10.1111/j.1523-1755.2004.00417.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Alpha-smooth muscle actin (α-SMA) expression in normal (A) and remnant (B) kidney cortex. In normal kidney, α-SMA expression is limited to vascular profiles. In contrast, in the remnant kidney, α-SMA expression is observed not only in the vascular tissue, but in tubular cells as well (asterisks) and in the peritubular interstitium. See Methods for details. Kidney International 2004 65, 409-419DOI: (10.1111/j.1523-1755.2004.00417.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Representative immunohistochemistry micrographs from remnant kidney cortex of rats that received vehicle (A,C,E,G) or hepatocyte growth factor (HGF) (B,D,F,H). (A and B) demonstrate that administration of HGF induces the expression of endothelin in tubules (asterisks and arrows) and in the juxtaglomerular apparatus (arrows in B). The expression of tissue inhibitor of metalloproteinase (TIMP)-2 (C and D) and plasminogen activator inhibitor-1 (PAI-1) (E and F) are decreased in the tubulointerstitial (arrows) compartment of remnant kidneys by HGF. (G and H) show that expression of metalloproteinase-9 (MMP-9) was significantly increased in HGF-treated rats in epithelial cells in both glomeruli and tubules (arrow and asterisks). See Methods for details. Kidney International 2004 65, 409-419DOI: (10.1111/j.1523-1755.2004.00417.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Effects of angiotensin II (Ang II) and hepatocyte growth factor (HGF) on mRNA levels of plasminogen activator inhibtor-1 (PAI-1), tissue inhibitor of metalloproteinase (TIMP)-2, and metalloproteinase-9 (MMP-9) in human proximal tubular epithelial cell (HKC) cells. HKC cells were treated with Ang II at 10-7or 10-6 mol/L in the presence or absence of HGF (20ng/mL) for 24hours. Total RNA was extracted and mRNA expression determined by semiquantitative polymerase chain reaction (PCR) (N = 6). GAPDH expression served as a control. Ang II induced expression of PAI-1 and TIMP-2, but not MMP-9, and this was attenuated by HGF. Kidney International 2004 65, 409-419DOI: (10.1111/j.1523-1755.2004.00417.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 6 (A and B) Apoptosis scores in glomeruli and tubules from remnant rats. There was no significant reduction in apoptosis in response to hepatocyte growth factor (HGF) in either glomeruli or in the tubulointerstitial compartment. See Methods for details. Kidney International 2004 65, 409-419DOI: (10.1111/j.1523-1755.2004.00417.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 7 Gene expression analysis profiles by dot blot of remnant kidneys from saline and hepatocyte growth factor (HGF)-infused rats. Each gene was blotted in duplicate. Quantitative hybridization units (PSL) normalized relative to the housekeeping gene GAPDH are presented. HGF failed to significantly alter the expression of any of the genes tested in this analysis. Kidney International 2004 65, 409-419DOI: (10.1111/j.1523-1755.2004.00417.x) Copyright © 2004 International Society of Nephrology Terms and Conditions